Skip to main content
Erschienen in: Supportive Care in Cancer 2/2014

01.02.2014 | Original Article

Predictors of anxiety and depression in people with colorectal cancer

verfasst von: Nicola M. Gray, Susan J. Hall, Susan Browne, Marie Johnston, Amanda J. Lee, Una Macleod, Elizabeth D. Mitchell, Leslie Samuel, Neil C. Campbell

Erschienen in: Supportive Care in Cancer | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

People living with colorectal cancer are at risk of anxiety and depression. We investigated what factors were most highly associated with these.

Methods

Four hundred and ninety-six people with colorectal cancer completed the Hospital Anxiety and Depression Scale (HADS). Data on functioning, symptoms, illness perceptions and social difficulties were collected by questionnaire. Case-note-identified disease, treatment and co-morbidity data were recorded. Multiple logistic regression identified factors independently predictive of anxiety and depression caseness.

Results

Self-reported history of anxiety/depression predicted anxiety but not depression caseness. Depression caseness predicted anxiety caseness (p = 0.043), as did poorer self-reported cognitive functioning (p = 0.001), dyspnoea (p = 0.015) or diarrhoea (p = 0.021), reporting a high negative life and emotional impact (p < 0.001) and having difficulties with finance (p = 0.007). Having neo-adjuvant radiotherapy increased the odds of depression caseness (p = 0.007), as did poorer physical (p = 0.007), cognitive (p < 0.001) and social (p < 0.001) functioning, having constipation (p = 0.011), reporting a high negative life and emotional impact (p < 0.001), having difficulties with personal care (p = 0.022) and communicating with others (p = 0.014).

Conclusion

Levels of anxiety caseness were similar to those of non-clinical samples, but depression caseness was higher, particularly in those who had received neo-adjuvant radiotherapy. Most factors associated with possible or probable depression may be modified with appropriate intervention.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
3.
Zurück zum Zitat Elliott J, Fallows A, Staetsky L, Smith PW, Foster CL, Maher EJ, Corner J (2011) The health and well-being of cancer survivors in the UK: findings from a population-based survey. Br J Cancer 105(Suppl 1):11–20. doi:10.1038/bjc.2011.418 CrossRef Elliott J, Fallows A, Staetsky L, Smith PW, Foster CL, Maher EJ, Corner J (2011) The health and well-being of cancer survivors in the UK: findings from a population-based survey. Br J Cancer 105(Suppl 1):11–20. doi:10.​1038/​bjc.​2011.​418 CrossRef
4.
Zurück zum Zitat Department of Health (2012) Quality of life of cancer survivors in England. Report on a pilot survey using Patient Reported Outcome Measures (PROMS). National Institute for Health Research, London Department of Health (2012) Quality of life of cancer survivors in England. Report on a pilot survey using Patient Reported Outcome Measures (PROMS). National Institute for Health Research, London
5.
Zurück zum Zitat Scottish Intercollegiate Guideline Network (SIGN) (2011) Diagnosis and management of colorectal cancer. Guideline number 126. SIGN, Edinburgh Scottish Intercollegiate Guideline Network (SIGN) (2011) Diagnosis and management of colorectal cancer. Guideline number 126. SIGN, Edinburgh
7.
Zurück zum Zitat Denlinger CS, Barsevick AM (2009) The challenges of colorectal cancer survivorship. J Natl Compr Canc Netw 7:883–894PubMedCentralPubMed Denlinger CS, Barsevick AM (2009) The challenges of colorectal cancer survivorship. J Natl Compr Canc Netw 7:883–894PubMedCentralPubMed
9.
Zurück zum Zitat Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M (2010) It’s not over when it’s over: long-term symptoms in cancer survivors—a systematic review. Int J Psychiatry Med 40:163–181PubMedCrossRef Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M (2010) It’s not over when it’s over: long-term symptoms in cancer survivors—a systematic review. Int J Psychiatry Med 40:163–181PubMedCrossRef
10.
Zurück zum Zitat Tsunoda A, Nakao K, Hiratsuka K, Yasuda N, Shibusawa M, Kusano M (2005) Anxiety, depression and quality of life in colorectal cancer patients. Int J Clin Oncol 10:411–417PubMedCrossRef Tsunoda A, Nakao K, Hiratsuka K, Yasuda N, Shibusawa M, Kusano M (2005) Anxiety, depression and quality of life in colorectal cancer patients. Int J Clin Oncol 10:411–417PubMedCrossRef
14.
Zurück zum Zitat Ramsey SD, Berry K, Moinpour C, Giedzinska A, Andersen MR (2002) Quality of life in long term survivors of colorectal cancer. Am J Gastroenterol 97:1228–1234PubMedCrossRef Ramsey SD, Berry K, Moinpour C, Giedzinska A, Andersen MR (2002) Quality of life in long term survivors of colorectal cancer. Am J Gastroenterol 97:1228–1234PubMedCrossRef
16.
Zurück zum Zitat Spiegel D, Giese-Davis J (2003) Depression and cancer: mechanisms and disease progression. Biol Psychiatry 54:269–282PubMedCrossRef Spiegel D, Giese-Davis J (2003) Depression and cancer: mechanisms and disease progression. Biol Psychiatry 54:269–282PubMedCrossRef
18.
Zurück zum Zitat Salvo N et al (2012) Frequency of reporting and predictive factors for anxiety and depression in patients with advanced cancer. Clin Oncol 24:139e–148eCrossRef Salvo N et al (2012) Frequency of reporting and predictive factors for anxiety and depression in patients with advanced cancer. Clin Oncol 24:139e–148eCrossRef
19.
Zurück zum Zitat Vodermaier A, Linden W, MacKenzie R, Greig D, Marshall C (2011) Disease stage predicts post-diagnosis anxiety and depression only in some types of cancer. Br J Cancer 105:1814–1817PubMedCentralPubMedCrossRef Vodermaier A, Linden W, MacKenzie R, Greig D, Marshall C (2011) Disease stage predicts post-diagnosis anxiety and depression only in some types of cancer. Br J Cancer 105:1814–1817PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Rhondali W, Perceau E, Berthiller J, Saltel P, Trillet-Lenoir V, Tredan O, Coulon JP, Bruera E, Filbet M (2012) Frequency of depression among oncology outpatients and association with other symptoms. Support Care Cancer 20:2795–2802. doi:10.1007/s00520-012-1401-3 PubMedCrossRef Rhondali W, Perceau E, Berthiller J, Saltel P, Trillet-Lenoir V, Tredan O, Coulon JP, Bruera E, Filbet M (2012) Frequency of depression among oncology outpatients and association with other symptoms. Support Care Cancer 20:2795–2802. doi:10.​1007/​s00520-012-1401-3 PubMedCrossRef
22.
Zurück zum Zitat Pereira MG, Figueiredo AP, Fincham FD (2012) Anxiety, depression, traumatic stress and quality of life in colorectal cancer after different treatments: a study with Portuguese patients and their partners. Eur J Oncol Nurs 16:227e–232eCrossRef Pereira MG, Figueiredo AP, Fincham FD (2012) Anxiety, depression, traumatic stress and quality of life in colorectal cancer after different treatments: a study with Portuguese patients and their partners. Eur J Oncol Nurs 16:227e–232eCrossRef
23.
Zurück zum Zitat Bang S, Park SH, Kang HG, Jue JI, Cho IH, Yun YH, Cho EK, Shin DB, Lee JH (2005) Changes in quality of life during palliative chemotherapy for solid cancer. Support Care Cancer 13:515–521PubMedCrossRef Bang S, Park SH, Kang HG, Jue JI, Cho IH, Yun YH, Cho EK, Shin DB, Lee JH (2005) Changes in quality of life during palliative chemotherapy for solid cancer. Support Care Cancer 13:515–521PubMedCrossRef
24.
Zurück zum Zitat Hodges K, Winstanley S (2012) Effects of optimism, social support, fighting spirit, cancer worry and internal health locus of control on positive affect in cancer survivors: a path analysis. Stress Heal 28:408–415. doi:10.1002/smi.2471 CrossRef Hodges K, Winstanley S (2012) Effects of optimism, social support, fighting spirit, cancer worry and internal health locus of control on positive affect in cancer survivors: a path analysis. Stress Heal 28:408–415. doi:10.​1002/​smi.​2471 CrossRef
25.
Zurück zum Zitat Husson O, Thong MS, Mols F, Oerlemans S, Kaptein AA, van de Poll-Franse LV (2013) Illness perceptions in cancer survivors: what is the role of information provision? Psycho-Oncology 22(3):490–498PubMedCrossRef Husson O, Thong MS, Mols F, Oerlemans S, Kaptein AA, van de Poll-Franse LV (2013) Illness perceptions in cancer survivors: what is the role of information provision? Psycho-Oncology 22(3):490–498PubMedCrossRef
28.
Zurück zum Zitat Groenvold M, Klee MC, Sprangers MAG, Aaronson NK (1997) Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol 50:441–450PubMedCrossRef Groenvold M, Klee MC, Sprangers MAG, Aaronson NK (1997) Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol 50:441–450PubMedCrossRef
30.
Zurück zum Zitat Wright P, Smith A, Roberts K, Selby P, Velikova G (2007) Screening for social difficulties in cancer patients: clinical utility of the social difficulties inventory. Br J Cancer 97:1063–1070PubMedCentralPubMedCrossRef Wright P, Smith A, Roberts K, Selby P, Velikova G (2007) Screening for social difficulties in cancer patients: clinical utility of the social difficulties inventory. Br J Cancer 97:1063–1070PubMedCentralPubMedCrossRef
31.
32.
Zurück zum Zitat Crawford JR, Henry JD, Crombie C, Taylor EP (2001) Normative data for the HADS from a large non-clinical sample. Br J Clin Psychol 40:429–434PubMedCrossRef Crawford JR, Henry JD, Crombie C, Taylor EP (2001) Normative data for the HADS from a large non-clinical sample. Br J Clin Psychol 40:429–434PubMedCrossRef
33.
Metadaten
Titel
Predictors of anxiety and depression in people with colorectal cancer
verfasst von
Nicola M. Gray
Susan J. Hall
Susan Browne
Marie Johnston
Amanda J. Lee
Una Macleod
Elizabeth D. Mitchell
Leslie Samuel
Neil C. Campbell
Publikationsdatum
01.02.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 2/2014
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-013-1963-8

Weitere Artikel der Ausgabe 2/2014

Supportive Care in Cancer 2/2014 Zur Ausgabe

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.